Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

NCT05143840 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukemia, Chronic Phase
Adult CML
Leukemia, Myeloid
Leukemia,Myeloid, Chronic

Interventions

DRUG: Single Agent Asciminib
COMBINATION_PRODUCT: Low TKI
OTHER: Elective Free Treatment

Sponsor

Augusta University

Collaborators

[object Object]